2990dkk
-2,0 %
Date:2024-07-24Time:16:59:00Latest report:Q2-2024List:Large CapTicker:EMBLA
Market Cap:12 786 mdkkEnterprise Value:16 058 mdkkNet Sales:819,7 musdEarnings:61,1 musdEmployees:0ISIN:IS0000000040

Ratios

10-year key figure history for Embla Medical turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Embla Medical with index and moving average MA50 and MA200.

Stockprice:29,90
MA50:28,47
MA200:29,30
Price/MA200:2,0 %
RSI (14):57,9
Price/MA50:5,0 %

Description

Embla Medical is engaged in the design, development, manufacturing and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Medical Equipment